(2R) -2-Deoxy-2-Fluoro-2-Methyl-D-Erythropentonic Acid y-Lactone 3,5-Dibenzoate CAS 874638-80-9

Table of Contents

• Product Overview & Specifications
• Detailed Applications
• Operational Guidelines
• Industry Case Studies
• Client Success Stories
• Contact for Technical Consultation

(2R)-2-Deoxy-2-Fluoro-2-Methyl-D-Erythropentonic Acid γ-Lactone 3,5-Dibenzoate Technical Specifications

Pharmaceutical Applications

This fluorinated lactone derivative serves as critical intermediate in:

1. Antiviral drug development (nucleoside analogs)
2. Protease inhibitor synthesis
3. Radiotracer compounds for PET imaging

Synthesis Protocol Example

Step 1: Dissolve 1mmol compound in anhydrous DCM (10mL)
Step 2: Add 1.2eq TMSOTf at -40°C under N₂
Step 3: React with protected ribose derivative (24h, RT)

Documented Research Applications

Client Implementation Cases

Case 1: Antiviral Drug Development

Client: Top 10 Pharma Company (Confidential)
Application: HBV inhibitor synthesis
Results: Achieved 92% coupling efficiency in nucleoside modification

Case 2: PET Tracer Production

Client: European Imaging Center
Application: ¹⁸F-labeled compound synthesis
Output: 97% radiochemical purity in final product

Technical & Commercial Inquiry

For batch-specific COA, custom synthesis requirements, or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826